Azelaic acid 15% gel once daily versus twice daily in papulopustular rosacea

Journal of Drugs in Dermatology

Volumn 7, Issue 6, 2008, Pages 541-546

  Thiboutot, Diane M ^a   Fleischer Jr , Alan B ^b   Del Rosso, James Q ^c   Graupe, Klaus ^d  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c TOURO UNIVERSITY NEVADA   (United States)

^d Intendis GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZELAIC ACID; DERMATOLOGICAL AGENT; DICARBOXYLIC ACID;

ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ADMINISTRATION; FEMALE; GEL; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; PATIENT COMPLIANCE; PATIENT SATISFACTION; RANDOMIZED CONTROLLED TRIAL; ROSACEA; TREATMENT OUTCOME;

DERMATOLOGIC AGENTS; DICARBOXYLIC ACIDS; DRUG ADMINISTRATION SCHEDULE; FEMALE; GELS; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT SATISFACTION; ROSACEA; TREATMENT OUTCOME;

EID: 47249130703     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). National Institutes of Health. US Department of Health and Human Services. What is Rosacea? Fast Facts: An Easy-to-Read Series of Publications for the Public. March 2005. Available at: http://www.niams.nih.gov/hi/topics/ rosacea/FF-Rosacea.pdf. Accessed August 13, 2007.
2. Wilkin J, Dahl M, Detmar M, et al. Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea. J Am Acad Dermatol. 2004;50:907-912. (Pubitemid 38685771)
3. Yamasaki K, Di Nardo A, Bardan A, et al. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat Med. 2007;13:975-980. (Pubitemid 47222043)
4. Elewski BE, Fleischer AB Jr, Pariser DM. A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial. Arch Dermatol. 2003;139:1444-1450. (Pubitemid 37433134)
5. Finacea [package insert]. Pinebrook, NJ: Intendis Inc; 2005.
6. Bikowski JB, Goldman MP. Rosacea: where are we now? J Drugs Dermatol. 2004;3:251-261.
7. Akamatsu H, Komura J, Asada Y, et al. Inhibitory effect of azelaic acid on neutrophil functions: a possible cause for its efficacy in treating pathogenetically unrelated diseases. Arch Dermatol Res. 1991;283:162-166.
8. Elewski BE. Azelaic acid 15% gel for treatment of rosacea. Expert Rev Dermatol. 2006;1:535-545.
9. IMS National Disease and Therapeutic Index™. MAT 7/2006-6/2007 data: Finacea® applications.
10. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001;23:1296-1310. (Pubitemid 32804122)
11. Guest JF, Davie AM, Ruiz FJ, Greener MJ. Switching asthma patients to a once-daily inhaled steroid improves compliance and reduces healthcare costs. Prim Care Respir J. 2005;14:88-98. (Pubitemid 40410057)
12. Stang P, Young S, Hogue S. Better patient persistence with once-daily bupropion compared with twice-daily bupropion. Am J Ther. 2007;14:20-24. (Pubitemid 46278665)
13. Kardas P. Comparison of patient compliance with once-daily and twice-daily antibiotic regimens in respiratory tract infections: results of a randomized trial. J Antimicrob Chemother. 2007;59:531-536. (Pubitemid 47073461)
14. Portsmouth SD, Osorio J, McCormick K, Gazzard BG, Moyle GJ. Better maintained adherence on switching from twice-daily to once-daily therapy for HIV: a 24-week randomized trial of treatment simplification using stavudine prolonged-release capsules. HIV Med. 2005;6:185-190. (Pubitemid 40740335)
15. Thiboutot D, Thieroff-Ekerdt R, Graupe K. Efficacy and safety of azelaic acid (15%) gel as a new treatment for papulopustular rosacea: results from two vehicle-controlled, randomized phase III studies. J Am Acad Dermatol. 2003;48:836-845. (Pubitemid 36706214)
16. Elewski BE, Fleischer AB Jr, Pariser DM. A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial. Arch Dermatol. 2003;139:1444-1450. (Pubitemid 37433134)
17. Zaghloul SS, Goodfield MJ. Objective assessment of compliance with psoriasis treatment. Arch Dermatol. 2004;140:408-414. (Pubitemid 38469243)
18. Jobling RG. Psoriasis - a preliminary questionnaire study of sufferers' subjective experience. Clin Exp Dermatol. 1976;1:233-236.
19. Serup J, Lindblad AK, Maroti M, et al. To follow or not to follow dermatological treatment - a review of the literature. Acta Derm Venereol. 2006;86:193-197. (Pubitemid 43875201)
20. Lee IA, Maibach HI. Pharmionics in dermatology: a review of topical medication adherence. Am J Clin Dermatol. 2006;7:231-236. (Pubitemid 44231918)